ArticleActa pharmacologica Sinica2024

A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer.

Hui-Fang Zong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.